PRESS RELEASE published on 07/09/2025 at 22:05, 11 months 3 days ago Inventiva annonce la nomination de Jason Campagna en tant que Président de la R&D et Directeur Médical et de Martine Zimmermann en tant que Vice-Présidente Exécutive en charge des affaires réglementaires et de l’assurance qualité Inventiva annonce la nomination de Jason Campagna en tant que Président de la R&D et Directeur Médical et de Martine Zimmermann en tant que Vice-Présidente Exécutive en charge des affaires réglementaires et de l’assurance qualité Nomination R&D Affaires Réglementaires Inventiva Lanifibranor
PRESS RELEASE published on 07/09/2025 at 22:05, 11 months 3 days ago Inventiva names Jason Campagna as President of R&D and Chief Medical Officer and Martine Zimmermann as Executive Vice President of Regulatory Affairs and Quality Assurance Inventiva appoints Jason Campagna as President of R&D and CMO and Martine Zimmermann as EVP of Regulatory Affairs and Quality Assurance, emphasizing long-term growth and operational excellence Quality Assurance R&D Leadership Appointments Regulatory Affairs Inventiva
BRIEF published on 07/07/2025 at 22:05, 11 months 5 days ago Inventiva Receives $10 Million Milestone Payment from CTTQ Milestone Payment Lanifibranor Biopharmaceutical Development MASH Treatment CTTQ Partnership
BRIEF published on 07/07/2025 at 22:05, 11 months 5 days ago Inventiva reçoit un paiement d'étape de 10 millions de dollars du CTTQ Paiement D'étape Lanifibranor Développement Biopharmaceutique Traitement MASH Partenariat CTTQ
PRESS RELEASE published on 07/07/2025 at 22:00, 11 months 5 days ago Inventiva receives $10 million milestone payment from CTTQ Inventiva receives $10 million milestone payment from CTTQ following successful structured financing. Partnership aims to develop lanifibranor for MASH treatment in Chinese regions Inventiva Milestone Payment MASH Lanifibranor CTTQ
PRESS RELEASE published on 07/07/2025 at 22:00, 11 months 5 days ago Inventiva receives $10 million milestone payment from CTTQ Inventiva reçoit un paiement d'étape de 10 millions de dollars de la part de CTTQ pour le développement de thérapies contre la stéatohépatite. Accord de licence avec potentiel de 265 millions de dollars supplémentaires Paiement Inventiva Stéatohépatite Thérapies CTTQ
BRIEF published on 07/02/2025 at 22:05, 11 months 10 days ago Inventiva Publishes Promising Results on Lanifibranor for Liver Disease Phase 2b Study Liver Disease Lanifibranor MASH Treatment Journal Of Hepatology Reports
BRIEF published on 07/02/2025 at 22:05, 11 months 10 days ago Inventiva publie des résultats prometteurs sur le lanifibranor pour les maladies du foie Étude De Phase 2b Maladie Du Foie Lanifibranor Traitement MASH Journal Des Rapports D'hépatologie
PRESS RELEASE published on 07/02/2025 at 22:00, 11 months 10 days ago Inventiva announces the publication in Journal of Hepatology Reports on results of lanifibranor treatment on liver sinusoidal endothelial cells in patients with MASLD/MASH and in preclinical models of the disease Inventiva announces publication in Journal of Hepatology Reports on lanifibranor treatment effects on liver sinusoidal endothelial cells in MASLD/MASH patients and preclinical models, showing potential therapeutic benefits Inventiva MASH Lanifibranor Journal Of Hepatology Reports LSEC Capillarization
PRESS RELEASE published on 07/02/2025 at 22:00, 11 months 10 days ago Inventiva annonce la publication dans le Journal of Hepatology Reports des résultats du lanifibranor sur les cellules endothéliales sinusoïdales hépatiques chez des patients MASLD/MASH et dans des modèles précliniques de la maladie Inventiva annonce la publication des résultats du lanifibranor sur les cellules endothéliales sinusoïdales hépatiques chez des patients MASLD/MASH. Des effets bénéfiques allant au-delà de l'inversion de la capillarisation ont été observés Inventiva MASH MASLD Lanifibranor Cellules Endothéliales
Published on 06/13/2026 at 04:50, 4 hours 48 minutes ago BTU Additional Details Regarding Recent Acquisition
Published on 06/13/2026 at 02:00, 7 hours 38 minutes ago Battery X Metals Appoints Automotive Industry Professional from Canadian Subsidiary of One of the World's Leading Premium Automobile Manufacturers, Headquartered in Munich, Germany, to its Advisory Board to Advance Commercialization of Its Patent-Pending
Published on 06/12/2026 at 23:15, 10 hours 23 minutes ago BioNxt Announces Non-Brokered Private Placement of Units Pursuant to the Listed Issuer Exemption
Published on 06/12/2026 at 22:30, 11 hours 8 minutes ago Fox River Provides Reminder To Vote And Updated Dissent Rights
Published on 06/12/2026 at 15:14, 18 hours 24 minutes ago Reeflex Solutions Inc. Reports Voting Results From Annual and Special Meeting of Shareholders
Published on 06/13/2026 at 08:18, 1 hour 20 minutes ago EQS-Adhoc: AT&S Austria Technologie & Systemtechnik AG: AT&S expands AI substrate capacity in Kulim and increases outlook for 2026/27
Published on 06/13/2026 at 01:05, 8 hours 33 minutes ago OpenText to Create 400 Jobs with €105 Million Investment in Cork and Galway to Expand Agentic AI and Sovereign Cloud in Europe
Published on 06/12/2026 at 22:50, 10 hours 48 minutes ago Bitmine Immersion Technologies Announces Initial Dividends and NYSE Listing for Series A Preferred Stock
Published on 06/12/2026 at 21:00, 12 hours 38 minutes ago Partners Group statement regarding its evergreen vehicles
Published on 06/12/2026 at 20:22, 13 hours 16 minutes ago Rumble Announces Discontinuation of Trading in Tendered Northern Data Shares (ISIN DE000A41YEL8) in the Exchange Offer
Published on 06/12/2026 at 18:31, 15 hours 7 minutes ago Share retention commitments (Dutreil agreement)
Published on 06/12/2026 at 17:45, 15 hours 53 minutes ago Engagements de conservation d’actions (Pacte Dutreil)
Published on 06/12/2026 at 16:19, 17 hours 19 minutes ago SMTPC - Communiqué sur la Reconduite des mandats du Président et du Directeur général
Published on 06/12/2026 at 12:56, 20 hours 42 minutes ago SIEHM-Avis de convocation à l'Assemblée Générale Extraordinaire du 30 juin 2026
Published on 06/12/2026 at 12:35, 21 hours 3 minutes ago SFCMC - Avis de convocation à l'Assemblée Générale Extraordinaire du 30 juin 2026